OmniActive Health Technologies, an ingredients supplier specializing in nutraceuticals, recently announced that TA Associates, a global growth private equity firm, has acquired a significant stake in the company. Founder and executive chairman Sanjaya Mariwala has further increased his personal holding, as well. The financial terms of the transaction were not disclosed.
 
OmniActive was founded in 2005, and offers a range of natural ingredients for both dietary supplements and fortified foods. The company works globally with nutrition brands and manufacturers through a solution-oriented approach, with R&D and manufacturing operations in Pune, Hosur, and Thane in India, and sales and distribution operations in the U.S., Europe, India, Asia, Australia, and Latin America.
 
“We are pleased to welcome TA Associates as a strategic investor and partner for the next phase of OmniActive’s growth journey,” Mariwala said. “We believe that TA has deep capabilities and experience investing in companies focused on nutritional ingredients, and shares OmniActive’s vision of bringing innovative, natural and science-based solutions to our customers and end consumers. We intend to leverage our strong management capabilities and TA’s distinctive M&A [mergers and acquisitions] sourcing engine to drive programmatic M&A and in-licensing to continuously deliver innovation to our customers.”
 
TA is focused on targeted sectors within technology, healthcare, financial services, consumer services, and business services, and has invested in more than 500 companies around the world.
 
“We believe that the nutritional ingredients space will see strong growth over the next decade,” Naresh Patwari, a director at TA Associates, said. “OmniActive has built a strong reputation and deep customer relationships by focusing on natural, R&D-led innovative ingredients. We look forward to working together with Mr. Mariwala and the OmniActive management team to further accelerate the growth in this business through organic levers and M&A.”
 
“We believe that TA’s global healthcare experience will be valuable in supporting OmniActive’s next phase of growth through continued organic growth and strategic acquisitions,” Jim Hamilton, CEO of OmniActive, added. “OmniActive has been growing at an accelerated pace, driven by a portfolio of branded, innovative natural products with clinically supported health benefits, and we are excited to continue this growth journey and supporting our customers with TA as our new equity partner.”
 
“We are impressed by the quality of OmniActive’s business and customer franchise,” Dhiraj Poddar, a managing director at TA Associates, said. “We believe that OmniActive is well-placed to benefit from the strong growth in the nutraceuticals ingredients space, and look forward to our partnership.”